Spark Therapeutics (ONCE), Pfizer (PFE) Announce Prelim. Data from SPK-9001 Phase 1/2 in Hemophilia B
Tweet Send to a Friend
Spark Therapeutics (Nasdaq: ONCE) and Pfizer Inc. (NYSE: PFE) announced updated preliminary data today from the first nine infused participants ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
